A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in type 2 (non-insulin-dependent) diabetes

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Diabetologia

• Publication date

  1982-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00254300PMID 6818080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Atherosclerosis in diabetes mellitus].

  1989cited by this paper
• Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association.

  1981cited by this paper
• Atherosclerosis in diabetes mellitus.

  1981cited by this paper
• High-density lipoprotein cholesterol and apolipoprotein A-I levels at diagnosis in patients with non-insulin dependent diabetes

  1981cited by this paper
• Sex differences in the relationships between obesity, alcohol consumption and cigarette smoking and serum lipid and apolipoprotein concentrations in a normal population.

  1981cited by this paper
• The continually changing 'natural history' of diabetes mellitus.

  1981cited by this paper
• FACTORS CONTRIBUTING TO DEATHS OF DIABETICS UNDER FIFTY YEARS OF AGE

  1981cited by this paper
• Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control.

  1978cited by this paper
• Serum high-density lipoproteins in peripheral vascular disease.

  1978cited by this paper
• Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purposes.

  1977cited by this paper
• High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

  1977cited by this paper
• Evaluation of a new enzymatic kit for serum triglycerides.

  1976cited by this paper
• Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up Study

  1974cited by this paper
• Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum.

  1973cited by this paper
• Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

  1970cited by this paper
• Ischemic Heart Disease, Atherosclerosis, and Longevity

  1966cited by this paper

• Glycosylated Haemoglobin (HbA1c) - A Marker of Circulating Lipids in Type 2 Diabetic Patients.

  2014cites this paper
• Sulphonylurea Antidiabetic Drugs

  2012cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2010cites this paper
• Lipo- and apolipoproteins in a population survey subset in MONICA-Israel.

  2009cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2006cites this paper
• Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles

  2004cites this paper
• Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus.

  2004cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.

  2003cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2002cites this paper
• A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus

  1999cites this paper
• Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus

  1998cites this paper
• [Value of biguanide in therapy of diabetes mellitus].

  1997cites this paper
• Die Transplantation hämatopoetischer Stammzellen

  1997cites this paper
• Acipimox attenuates hypertriglyceridemia in dyslipidemic noninsulin dependent diabetes mellitus patients without perturbation of insulin sensitivity and glycemic control.

  1997cites this paper
• Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study.

  1997cites this paper
• Increased alanine uptake and lipid synthesis from alanine in isolated hepatocytes of Wistar-Kyoto fatty rats: an inhibitory effect of biguanides.

  1997cites this paper
• Die Stellung der Biguanide in der Therapie des Diabetes mellitus

  1997cites this paper
• Triglyceride‐rich lipoproteins in non‐insulin‐dependent diabetes mellitus: post‐prandial metabolism and relation to premature atherosclerosis

  1996cites this paper
• Metabolic and dietary determinants of serum lipids in obese patients with recently diagnosed non-insulin-dependent diabetes.

  1994cites this paper
• Possible Link Between a Low Prevalence of Cardiovascular Disease and Mild Dyslipidaemia: a Study in Japanese Patients with Type 2 Diabetes

  1993cites this paper
• Diabetic Macrovascular Disease and Serum Lipids: Is There a Connection?

  1992cites this paper
• The Effect of Acipimox in Patients with Type 2 Diabetes and Persistent Hyperlipidaemia

  1992cites this paper
• Serum lipid and apolipoprotein levels in non‐hypertensive lean NIDDM patients

  1991cites this paper
• Management of newly diagnosed non-insulin-dependent (type 2) diabetes mellitus: a retrospective audit.

  1991cites this paper
• Treatment of diabetes: the effect on serum lipids and lipoproteins.

  1991cites this paper
• Hyperlipidemia in diabetes mellitus.

  1990cites this paper
• Lipids, Diabetes, and Vascular Disease: The Time to Act

  1989cites this paper
• Diabetes care: activity and costs.

  1989cites this paper
• Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

  1989cites this paper
• The Effect of Glibenclamide and Metformin on Serum Lipoproteins in Type 2 Diabetes

  1988cites this paper
• Meta-analysis of the effects of educational and psychosocial interventions on management of diabetes mellitus.

  1988cites this paper
• The Effect of Metformin on Glycaemic Control, Intermediary Metabolism and Blood Pressure in Non‐insulin‐dependent Diabetes Mellitus

  1987cites this paper
• Adverse Cardiovascular Effects of Sulphonylurea Drugs

  1987cites this paper
• Diabetes and atherosclerosis: an epidemiologic view.

  1987cites this paper
• Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Pathogenesis and treatment.

  1987cites this paper
• HDL metabolism in diabetes.

  1987cites this paper
• Fettstoffwechsel bei Typ II Diabetes mellitus

  1986cites this paper
• Chlorpropamide Lowers Serum and Lipoprotein Cholesterol in Insulin‐Dependent Diabetes

  1986cites this paper
• Effect of diabetes mellitus and end-stage renal disease on HDL metabolism.

  1986cites this paper
• Effect of sulfonylurea therapy on plasma lipids and high-density lipoprotein composition in non-insulin-dependent diabetes mellitus.

  1985cites this paper
• INSULIN RESISTANCE IN CIRRHOSIS: EVIDENCE FOR A POST‐RECEPTOR DEFECT

  1984cites this paper